|
Adrienne Blanchard is Vice-Chair (Biotech) of the Firm’s Life Sciences Industry Group. She practises primarily in the areas of pharmaceutical regulation, with a focus on compliance under the Food and Drugs Act, as well as pricing/reimbursement, and as well, in the field of intellectual property including trade-marks.
In the field of pharmaceuticals, Ms. Blanchard is an advocate for client interests, before regulatory bodies including Health Canada. In addition, she has appeared before Parliamentary and Senate committees on issues of concern to the innovative pharmaceutical industry.
Ms. Blanchard is a frequent speaker and author on pharmaceutical issues, and has developed an expertise in the regulation of subsequent entry biologics.
In her intellectual property practice, Ms. Blanchard practices primarily in the field of trade-marks, advising on a full range of prosecution matters, including trade-mark searching, preparing registrability opinions, prosecuting trademark applications and conducting trade-mark opposition matters before the Canadian Trade-marks Office.
Ms. Blanchard joined Gowlings in 1998. She is a member of BIOTECanada’s Health Policy Advisory Board and its Subsequent Entry Biologics Task Force. Ms. Blanchard is a member of the Intellectual Property Owners’ (IPO) Association’s committee on Pharmaceutical Issues, and its subcommittee on Follow-On Biologics. She is also the founding Executive Editor of Drug Pricing and Reimbursement@Gowlings, an electronic newsletter published by the Firm. Ms. Blanchard is a member of the Intellectual Property Institute of Canada (IPIC) where she chaired the Intellectual Property Trade Policy Committee from 1999 - 2009.
Ms. Blanchard is co-editor of the publication Life Sciences Law in Canada (Carswell, 2006) and co-author of the text A Practical Guide to IP Issues in the Pharmaceutical Industry (EIPR/Sweet Maxwell, 2007). Article: Food and Drug Law Institute, UPDATE Magazine (January 2010): Drug Pricing and Market Access
Chair, Canadian Institute, June 16-17, 2009: Drug Pricing and Reimbursement Conference,
Article: Food and Drug Law Institute, UPDATE Magazine (July 2009): Health Canada Aims to Finalize its Biosimilar Pathway Guidances
Chapter: Global Pharmacovigilance Book, published by the Food and Drug Law Institute, 2009.
Presentation, Licensing Executives Society Annual Meeting (October 2008): WTO General Council Decision on Access to Medicines
Presentation, Canadian Association of Professional Regulatory Affairs Annual Meeting (October 6, 2008): Progressive Licensing – Legal Issues
Chair, Canadian Institute Conference (April 2008): Product Life Cycle Management |
